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CytotoxicityAbstract Syntheses and characterization (1H & 13C NMR and CHN) of four new thiosemicar-
bazone derivatives (1–4) are reported. The molecular structures of compounds 1–4 were determined
using single crystal X-ray crystallographic technique. Cytotoxic effect of all the compounds was
determined against three cancerous (PANC-1, HCT 116 and MCF-7) and one non-cancerous
(NIH/3T3) cell lines. All the compounds remained safe against non-cancerous cells (IC50 > 500 -
lM) but induced significant cytotoxicity in the cancerous cell lines. Importantly, compounds 2
and 4 showed excellent cytotoxicity (IC50 = 10.0 and 0.7 lM against PANC-1; 14.9 and 9.4 lM
against HCT 116; 14.3 and 15.8 lM against MCF-7 for 2 and 4 respectively). Based on the results
it can be concluded that the thiosemicarbazone derivatives (2 and 4) can be further studied in detail
for the purpose of chemotherapeutic drug development.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Thiosemicarbazones are a class of compounds having general
structure R1R2C‚NANHACSANH2. These compounds can
be synthesized by condensation of thiosemicarbazide with suit-
able aldehydes and ketones (Casas et al., 2000). Furthermore,
suitable variations (substitutions) on either thioamide nitrogen
atom, sulfur atom, or hydrazine nitrogen atoms provide inter-
esting derivatives (Fig. 1).
Thiosemicarbazone molecules react with a wide range of
metal cations to form metal complexes. The exploration of
the antiviral, antibacterial, and antitumor properties of the
thiosemicarbazones and their metal complexes has urgedurnal of
Figure 1 Possible derivatives of thiosemicarbzides which can be
obtained by substituting at, (a) thioamide nitrogen atom labeled as
N4, (b) sulfur atom, and (c) hydrazine nitrogen atom.
2 M.A. Hussein et al.numerous investigations related to the catalysis and biological
importance (Ferrari et al., 2004; Afrasiabi et al., 2004; Hu
et al., 2006; Ðilovic´ et al., 2008; Kalaivani et al., 2012a,b;
Yousef et al., 2013; Khandani et al., 2013; Demoro et al.,
2013; Matesanz et al., 2013; Chandra et al., 2013;
Sankaraperumal et al., 2013; Kunos et al., 2013; Moradi-
Shoeili et al., 2013; Lukmantara et al., 2013; Su et al., 2013;
Ermut et al., 2013; Markovic´ et al., 2013; Kovala-Demertzi
et al., 2004; Pingaew et al., 2013; Hussein et al., 2014). A num-
ber of thiosemicarbazone derivatives were synthesized and
reported as potential anticarcinogenic (Lukmantara et al.,
2013; Ermut et al., 2013; Pingaew et al., 2013). For example,
Lukmantara and co-workers synthesized a series of thiosemi-
carbazone derivatives, mainly by varying the substitutions at
thioamide nitrogen (Fig. 2A). All the synthesized compounds
were screened against human neuroblastoma (SK-N-MC)
and human feta lung fibroblast (MRC-5) cell lines which
showed significant anticancer activity (Lukmantara et al.,Figure 2 Thiosemicarbazone derivatives reported recently as
anticarcinogenic compounds.
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carbazone derivatives (Fig. 2B), also by varying substitutions
at thioamide nitrogen. All the compounds were screened
against cervical cancer cell line (HeLa). Pingaew et al (2013)
reported the syntheses of a series novel thiosemicarbazone
derivatives (Fig. 2C) and their anticancer properties against
four human cancerous cell lines namely cholangiocarcinoma
(HuCCA-1), liver carcinoma (HepG2), lung carcinoma
(A549) and acute lymphoblastic leukemia (MOLT-3). The sig-
nificant anticancer properties were reported. Triapine is among
the thiosemicarbazones which has been studied in detail for its
anticancer properties (Ishiguro et al., 2015; Altintop et al.,
2015; Rand et al., 2015; Trondl et al., 2014; Kunos and
Sherertz, 2014; Merlot et al., 2015; Jansson et al., 2015).
The structure–activity relationship studies have shown that
thiosemicarbazone derivatives containing phenolic groups
have interesting anticancer properties (Baldini et al., 2003;
Bisceglie et al., 2007; Ramachandran et al., 2012; Sampath
et al., 2013). It has been observed that various substitutions
(including nitro, methoxy, phenolic, etc.) at the thioamide
nitrogen atoms, N(4), have significant effect on the biological
efficacy of these compounds (Kowol et al., 2007; Mendes
et al., 2009; Bernhardt et al., 2008). For example, the heterocyc
lic-N(4)-thiosemicarbazones have shown promising activity
against breast cancer (Zeglis et al., 2011) as well as the presence
of aromatic group at N(4) of isatin-b thiosemicarbazones
derivatives has shown increased cytotoxicity against the paren-
tal KB-3-1 cell lines and the P-glycoprotein-expressing cell line
KB-V1 (Hall et al., 2011). Herein, we describe the synthesis of
some new thiosemicarbazone derivatives with various substitu-
tions at terminal nitrogen (R3) as well as at the benzene ring
(R1 and R2) as shown in Scheme 1, to further study this
phenomenon.Scheme 1 Syntheses of thiosemicarbazone derivatives (1–4) by
refluxing different hydroxybenzaldehydes (A) and thiosemicar-
bazide (B) in ethanol.
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2.1. Synthesis
New thiosemicarbazones (1–4) were prepared by condensation
of thiosemicarbazide, 4-phenylthiosemicarbazide, 4-
dimethylthiosemicarbazide and 4-ethylthiosemicarbazide with
corresponding aldehyde derivatives (Vrdoljak et al., 2005).
The substitutions (NO2, OCH3, CH2‚CHCH2) were used to
observe their effects on the biological efficacy. In the reaction
medium compounds appeared either as white or yellow pow-
derous material and were collected after filtration. Each of
the products so obtained was washed with the fresh and cooled
ethanol to remove the unreacted material and recrystalized.
Each of the compounds was found to be easily soluble in
DMF and DMSO. The assigned structures were confirmed
by 1H NMR, 13C NMR and elemental analysis.
2.2. Characterization by NMR
In general, for all the synthesized compounds, the aromatic
CAH chemical shifts appeared in the range 6.78–8.37 d ppm.
This is in accordance with the previous reports having similar
structural features (Hu et al., 2006; Ðilovic´ et al., 2008).
Importantly, compound 1 showed aromatic chemical shifts
in the downfield region (7.05–8.37 d ppm) which might be
due to electron withdrawing effect of nitro group
(R2 = NO2) attached to the benzene ring. In rest of the three
compounds (2–4) these ranges remained almost comparable
(6.78–7.55 d ppm). Furthermore, the chemical shifts for
ACH‚NA group in all the synthesized compounds appeared
at 8.60 ± 0.20 d ppm which is in accordance with the reports
involving thiosemicarbazones (Pingaew et al., 2013; Ðilovic´
et al., 2008). TheANANHA proton peaks appeared at compa-
rable region (11.44 ± 0.04 d ppm), except this chemical shift in
4 which appeared at 11.77 d ppm. This might be due to the
presence of a phenyl group in 4 (R3 = C6H5) which might
have induced electron withdrawing inductive effect that ulti-
mately shifted the labeled peak toward downfield region com-
pared to the other compounds of its class. The chemical shifts
for rest of the substitutions (methoxy, allyl and alkyl) appeared
in the range below 6.00 d ppm.
Similarly, in 13C NMR spectral features, the aromatic car-
bon chemical shifts appeared in the range 111.0–144.3 d ppm
(Ðilovic´ et al., 2008; Hu et al., 2006). Noticeably, in 13C
NMR, compound 1 showed aromatic carbon chemical shifts
in the upfield region (111.0–37.6 d ppm) compared to the other
members of its class (2–4). It is important to highlight that in
1H NMR (as stated above) the respective aromatic CAH
chemical shifts appeared downfield compared to the other
members of its class whereas in 13C NMR these appeared in
the upfield region. The exact reason of this observation is
not clear however; the observed phenomenon has been
reported to be noticed. Furthermore, the ACH‚NA chemical
shift for Cl and NO2 substituted compounds (1–2) appeared at
comparable region (155.5 ± 0.1 d ppm) whereas for allyl sub-
stituted compounds (3–4) at comparatively upfield region
(147.8 d ppm). The C‚S chemical shifts appeared in the range
176.3–177.7 d ppm and were found comparable with the liter-
ature (Pingaew et al., 2013; Afrasiabi et al., 2004; Chen
et al., 2004). The chemical shifts for rest of the moietiesPlease cite this article in press as: Hussein, M.A. et al., Synthesis, structural elucidat
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.08.013(alkyl and methoxy groups) appeared in the range 14.4–
55.8 d ppm.
2.3. Crystallographic study
The crystallographic section describes the crystal structures of
thiosemicarbazones (1–4). The crystallographic data have been
provided in Table 1. The selected bond lengths and angles have
been listed in Table 2 and their molecular structures have been
shown in Figs. 3 and 4. It can be noticed that although both
the compounds (1 and 3) have different substitutions at R1,
R2 and R3 positions (Scheme 1), the compounds crystallized
in the same crystal system (Triclinic) and the same space group
(Pi). However, their asymmetric unit cells contain different
number of molecules (2 molecules in the unit cell of 1 and 4
in case of 3). Furthermore, it can be noticed that the asymmet-
ric units of 1 and 3 contain two crystallographically indepen-
dent molecules (Rubcˇic´ et al., 2008; Hassan et al., 2014;
Seidel et al., 2013). This characteristic was not found in rest
of the compounds (2 and 4). Unlike 1 and 3, the compounds
2 and 4 crystallized in the monoclinic crystal system but in dif-
ferent space groups (P21/c for 2 and C2/c for 4). Among the
crystallized compounds, maximum number of molecules were
found in the asymmetric unit of 4 (8 molecules) with the max-
imum unit cell volume of 3353.8(2) A˚3. The compound 4 has
the highest melting point (228 C) among the test compounds
which might be due to the strong intermolecular interactions
and molecular packing as discussed below.
The crystallized molecules packed through the H-bondings
and close p–p stacking interactions. For example, in com-
pound 1 the molecules were found to have intermolecular H-
bondings between phenolic and nitro groups (1.976 A˚) as well
as between sulfur atom of the molecule and hydrogen atom of
solvent methanol (2.482 A˚), see Fig. S9. Similarly, compound 2
has H-bonding between sulfur atom and methylenehydrazine
group hydrogen atoms (2.729 A˚) in a ‘‘V” shape and also
between the oxygen atom of phenol group and aromatic ring
hydrogen atom (Fig. S10). Compound 3 has intramolecular
H-bondings in addition to the intermolecular H-bondings
(Fig. S11).The hydrazine nitrogen atoms have intramolecular
H-bonding with the phenolic oxygen atom (2.623 A˚) and the
intermolecular H-bonding between methoxy oxygen atom
and hydrogen atoms of alkyl chains (Fig. S11). Compound 4
has similar but dense intra and intermolecular interactions
(Fig. S12) compared to the other molecules (1–3). This is per-
haps the reason that compound 4 has the highest melting point
among the synthesized compounds. The molecular structures
of 2 and 4 were found to have single firm units (Fig. 4).
In general, the molecular structures of 1, 3 and 4 showed
anti orientation of N1 in relation to S, and syn orientation in
relation to N3 (Fig. 5B). The terminal C9 atom of 1 and 4 is
anti in relation to N2, and syn in relation to S. However, the
compound 2 showed different orientations than compared to
1, 3 and 4. The nitrogen N1 is syn in relation to S, and anti
in relation to N3 (Fig. 5A). The terminal carbon (C10) showed
the syn geometry in relation to S, and the anti in relation to
N2, whereas the other terminal C9 showed the contradictory
orientation in relation to S and N2. Fig. 5 highlights selected
geometrical orientations as described above.
Furthermore, the asymmetric unit of 3 contains two inde-
pendent molecules (A and B), see Fig. 6. These moleculesion and cytotoxicity of new thiosemicarbazone derivatives. Arabian Journal of
Table 1 Crystallographic data of compounds 1–4.
Parameter 1 2 3 4
Empirical formula C10H12N4O3S,CH4O C10H12ClN3OS C12H15N3O2S C18H19N3O2S
Formula weight 297.24 257.75 265.34 341.43
Temperature (K) 100 100 100 100
Radiation/
wavelength
Mo Ka/0.71073 A˚ Mo Ka/0.71073 A˚ Mo Ka/0.71073 A˚ Mo Ka/0.71073 A˚
Crystal morphology
and color
Blocks/yellow Needles/brown Plates/yellow Blocks/yellow
Crystal system,
space group
Triclinic, Pi Monoclinic, P21/c Triclinic, Pi Monoclinic, C2/c
Unit cell dimensions a= 7.0270(2) A˚ a= 13.6811(12)A˚ a= 10.5445(2)A˚ a= 30.9436(11)A˚
b= 12.4004(4) A˚ b= 6.9785(6)A˚ b= 11.2670(2)A˚ b= 6.1094(2)A˚
c= 16.3121(5) A˚ c= 12.3973(11)A˚ c= 11.4921(2)A˚ c= 18.0439(7))A˚
a= 69.310(2) a= 90 a= 78.678(1) a= 90
b= 85.745(2) b= 102.324(2) b= 80.444(1) b= 100.518(2)
c= 85.452(2) c= 90 c= 72.488(1) c= 90
Volume (A˚3) 1323.91(7) 1156.34(18) 1268.33(4) 3353.8(2)
Z, Calculated
density (Mg/m3)
2, 1.426 4, 1.480 4, 1.390 8, 1.352
F(000) 596 536 560 1440
Crystal size (mm3) 0.12  0.29  0.61 0.07  0.25  0.49 0.08  0.21  0.46 0.12  0.16  0.56
h range for data () 1.8–30.0 3.0–30.6 1.8–30.2 2.3–30.5
Limiting indices 9 6 h 6 9, 17 6 k 6 17,
22 6 l 6 22
19 6 h 6 17, 9 6 k 6 9,
17 6 l 6 17
14 6 h 6 14,
15 6 k 6 15, 15 6 l 6 16
43 6 h 6 44, 8 6 k 6 8,
25 6 l 6 25
Reflections
collected/unique
23,890/7643 11,491/3530 27,320/7398 19,809/5095
R (int) 0.043 0.047 0.054 0.042
Goodness of fit (S) 1.1 1.04 1.04 1.07
R [F2 > 2r(F2)], wR
(F2)
0.0572, 0.1297 0.0410, 0.1038 0.0513, 0.1131 0.0519, 0.1376
Observed data
[I> 2r(I)]
5842 2480 4782 3813
Table 2 Selected bond length (A˚) and bond angles () for compounds 1–4.
Bonds 1 A, B 2 3 A, B 4
Bond lengths
S1AC8 [1.695(2), 1.707(2)] 1.6818(18) [1.6969(19), 1.6958(19)] 1.6863(19)
N1AN2 [1.373(3), 1.380(3)] 1.364(2) [1.382(2), 1.374(2)] 1.3747(18)
N1AC7 [1.283(3), 1.285(3)] 1.281(2) [1.284(2), 1.289(2)] 1.285(2)
N2AC8 [1.365(3), 1.354(3)] 1.368(2) [1.344(2), 1.351(2)] 1.359(2)
N3AC8 [1.325(3), 1.322(3)] 1.342(2) [1.329(2), 1.324(2)] 1.433(2)
N3AC9 [1.456(3), 1.459(3)] 1.468(2) 1.433(2)
C6AC7 [1.468(3), 1.461(3)] 1.457(3) [1.465(3), 1.462(3)] 1.464(3)
Bond angles
N2AN1AC7 [116.9(2), 114.37(19)] 119.04(15) [115.99(15), 117.94(15)] 115.43(15)
N1AN2AC8 [118.1(2), 120.18(19)] 118.35(14) [118.94(15), 120.15(15)] 1.3747(18)
C8AN3AC9 [125.9(2), 125.5(2)] 121.69(15) - 125.19(17)
S1AC8AN2 [118.49(17), 18.11(16)] 120.83(14) [120.12(14), 119.69(14)] 119.61(13)
S1AC8AN3 [125.29(19), 24.46(18)] 123.85(13) [122.67(15), 122.28(14)] 125.18(13)
N2AC8AN3 [116.2(2), 117.4(2)] 115.31(15) [117.21(17), 118.03(17)] 115.21(16)
Note: The assignments A and B for compounds 1 and 3 represent the bond angles and bond lengths of crystallographically different units (A
and B) of same compound.
4 M.A. Hussein et al.showed different conformations, the salicylaldimine plane of
B, containing O1, N1 and C1AC7, rotates approximately
180 around C7AN1 bond compared to that of unit A, leads
to change the anti geometry between C1 and N1 atoms in A
to syn geometry in B. The SAC8 bond distance is longer than
the N2AC8 bond distance, which indicates the compounds are
present in the thione form.Please cite this article in press as: Hussein, M.A. et al., Synthesis, structural elucida
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.08.0132.4. In vitro anticancer study
All the synthesized compounds were tested for their inhibitory
potential on the proliferation of three cancerous cell lines,
namely pancreas cancer (PANC-1), breast cancer (MCF-7)
and human colon cancer (HCT-116) as well as on the normal
mouse fibroblasts NIH/3T3 cells using MTT assay. The mediantion and cytotoxicity of new thiosemicarbazone derivatives. Arabian Journal of
Figure 3 (A and B): (A) Molecular structure of compound 1 drawn at 50% probability, having two crystallographically independent
molecules interacted by p–p stacking interactions. Both the units have slightly different geometric parameters. A methanol molecule was
found to be packed along with the molecules of 1. (B) Molecular structure of 3 drawn at 50% probability, having two crystallographically
independent molecules. Both the units have slightly different geometric parameters but same in all the chemical characteristics.
New thiosemicarbazone derivatives 5inhibitory concentrations (IC50) of test compounds are given in
Table 3 whereas the photomicrographs of the treated cells are
presented in Fig. 7. The compounds showed considerable cyto-
toxic effect on the three cancerous cell lines; however, none of
the test compounds was found cytotoxic in normal mouse
fibroblasts. PANC-1 was the most sensitive cell line to the
cytotoxic potential of the test compounds where the IC50 of
1–4 was between 0.73 and 13.7 lM. Interestingly, the cytotoxic
effect of compounds 2 and 4 was found to be stronger than
that of 1 and 3. Although the cytotoxic effect of the test com-
pounds was not as much stronger in MCF-7 and HCT-116
cells as it was in PANC-1 cells, 2 and 4 showed considerable
cytotoxic effect in the two mentioned cell lines as well
(IC50 < 16 lM). This relative increase in the cytotoxic poten-
tial of 2 and 4 may be attributed to the presence of R3Please cite this article in press as: Hussein, M.A. et al., Synthesis, structural elucidat
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.08.013(C6H5) and R2 (Cl) groups in 2 and 4 respectively, as the activ-
ity reduced by the substitution of these groups by H and NO2
in 1 and 3 respectively. Furthermore, the cytotoxic potential of
1 and 4 may also be attributed to the presence of the terminal
methyl and phenyl groups. These groups may help in interac-
tive properties of a compound which may lead to these mole-
cules to cross the cell wall barriers and let them interact with
the DNA. Moreover, the presence of chlorine group in 1
may have enhanced its biological properties. In the recent year,
a number of thiosemicarbazones have been synthesized and
screened against various cell lines (Vandresen et al., 2014),
where the thiosemicarbazones having halide showed noticeable
activity. The effect of functional groups on the biological effi-
cacy has always been significant (Wang et al., 2015; Duan and
Zhang, 2011).ion and cytotoxicity of new thiosemicarbazone derivatives. Arabian Journal of
Figure 4 Molecular structures of 2 (A) and 4 (B) drawn at 50% probability.
Figure 5 Showing the syn- and anti- relation of N1 to S and N3
in compounds 1–4. All the orientations have been assigned
according to the crystallographic data collected for these
compounds.
Figure 6 Showing different confirmations of compound 3 based
on crystallographic elucidation.
6 M.A. Hussein et al.3. Experimental
3.1. Materials and instrumentation
Melting points were determined using a Stuart Scientific SMP1
melting point apparatus. NMR (1H and 13C) spectra were
recorded on a Bruker spectrophotometer at 500 and
400 MHz using tetramethylsilane as an internal standard and
DMSO-d6 as the solvent. Elemental analysis was performed
using a Perkin Elmer 2400 series-11 CHN analyzer. X-ray crys-
tallographic experiments were performed on a Bruker SMARTPlease cite this article in press as: Hussein, M.A. et al., Synthesis, structural elucida
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.08.013APEXII CCD area-detector diffractometer using graphite
monochromated Mo Ka radiation (k= 0.71073 A˚) at 100 K.
The data were collected and reduced using APEX2 and
SAINT programs. The structural features of all compounds
were solved using the SHELXS-97 program package, and
refined using the SHELXL-97 program (Sheldrick, 2008). All
non-hydrogen atoms were anisotropically refined. The molec-
ular graphics were created using SHELXTL. The single crys-
tals of synthesized compounds (1–4) were obtained by slow
evaporation method. According to this method, a saturated
solution of each of the compounds in a suitable solvent
(DMF or methanol) was sealed in a beaker using parafilm
and then small holes were made into it using needle to let
the solvent evaporate at slower rate. The crystals appearedtion and cytotoxicity of new thiosemicarbazone derivatives. Arabian Journal of
Table 3 IC50 values (lM) of compounds 1–4 tested against cancerous and non-cancerous cell lines.
Carcinoma cell lines Normal cell line
Cell lines PANC-1 HCT 116 MCF-7 NIH.3T3
Compounds 1 13.7 71.2 54.2 >500
2 10.0 14.9 14.3 >500
3 1.7 212.8 127.7 >500
4 0.7 9.4 15.8 >500
Standards 5-Flourouracil 5-Flourouracil Betulinic acid Betulinic acid
96.8 21.0 44.1 28.4
Figure 7 Photomicrographs of PANC-1, MCF-7, HCT-116 and NIH/3T3 cells treated with compounds 1–4. The images of cells were
taken by a phase-contrast microscope (20 magnification) at the 48th hour of treatment with test drugs.
New thiosemicarbazone derivatives 7and suitable crystals were selected for crystallography. All
chemicals, including thiosemicarbazide, aldehydes, and sol-
vents, were purchased from Sigma–Aldrich.
3.2. Synthesis
Compounds (1–4) were prepared by reacting equimolar
ethanolic solutions of respective aldehyde derivative and the
corresponding thiosemicarbazide. The reaction mixture was
refluxed with stirring for 2 h. The product was filtered, washed
with ethanol, recrystalized and air-dried. The single crystals of
2, 3 and 4, suitable for X-ray crystallographic analysis, were
obtained by the slow evaporation of DMF solution at room
temperature. The crystals of 1 were obtained by slow evapora-
tion of methanol solution at room temperature.
3.2.1. N-ethyl-2-(5-nitro-2-hydroxybenzylidene) hydrazine
carbothioamide (1)
A solution of 5-nitro-2-hydroxybenzaldehyde (0.70 g,
4.19 mmol) in ethanol (20 ml) was added to a solution ofPlease cite this article in press as: Hussein, M.A. et al., Synthesis, structural elucidat
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.08.0134-ethyl-3-thiosemicarbazide (0.5 g, 4.19 mmol) in ethanol
(20 ml). The resulting yellow solution was refluxed with stir-
ring for 2 h. A yellow product formed when the solution
cooled down to room temperature, then filtered, washed with
fresh ethanol, recrystalized and air-dried. Needle yellow crys-
tals were obtained by slow evaporation of its saturated
dimethylformamide (DMF) solution at room temperature.
m.p: 221–223 C, (0.83 g, 79%). Anal. Calc. for C10H12N4O3-
S: C, 47.55; H, 4.75; N, 22.19. Found: C, 47.89; H, 4.68; N,
22.21%; 1H NMR (DMSO-d6, d ppm): 1.03 (t, CH3), 3.41
(dd, CH2), 7.05, 8.13, 8.37 (d, d, s, H-aromatic), 8.73 (s,
CSANH), 8.81 (s, CH‚N), 11.48 (s, N-NH); 13C NMR
(DMSO-d6, d ppm): 14.4 (CH3), 30.5 (CH2), 111.0–137.6
(C-aromatic), 155.4 (C‚N), 176.3 (C‚S).
3.2.2. N-dimethyl-2-(5-chloro-2-hydroxybenzylidene) hydrazine
carbothioamide (2)
A solution of 5-chloro-2-hydroxybenzaldehyde (0.65 g,
4.19 mmol) in ethanol (20 ml) was added slowly to a solution
of 4-dimethyl-3-thiosemicarbazide (0.5 g, 4.19 mmol) in ethanolion and cytotoxicity of new thiosemicarbazone derivatives. Arabian Journal of
8 M.A. Hussein et al.(20 ml). The resulting yellow solution was refluxed with stirring
for 2 h. White precipitates appeared when the solution cooled
down to room temperature, then filtered and washed with fresh
ethanol. The resulting material was recrystalized and air-dried.
Colorless plates like crystals were obtained by slow evaporation
of a saturated DMF solution at room temperature. m.p: 177–
179 C, (0.82 g, 76%). Anal. Calc. for C10H12ClN3OS: C,
46.55; H, 4.65; N, 16.29. Found: C, 47.00; H, 4.68; N, 16.52%;
1H NMR (DMSO-d6, d ppm): 3.30 (CH3), 6.91, 7.28, 7.47 (H-
aromatic), 8.43 (CH‚N), 11.40 (NANH); 13C NMR (DMSO-
d6, ppm): 41.0 (CH3), 118.4–144.6 (C-aromatic), 155.6 (C‚N),
179.1 (C‚S).
3.2.3. 2-(5-allyl-3-methoxy-2-hydroxybenzylidene) hydrazine
carbothioamide (3)
A solution of 5-allyl-3-methoxy-2-hydroxybenzaldehyde
(1.05 g, 5.48 mmol) in ethanol (20 ml) was added to a solution
of thiosemicarbazide (0.5 g, 5.48 mmol) in ethanol (20 ml). The
resulting colorless solution was refluxed with stirring for 2 h. A
white fluffy product appeared when the solution cooled down
to the room temperature, which was then filtered and washed
with fresh ethanol. The resulting material was recrystalized
and air-dried. Yellow plates like crystals were obtained by slow
evaporation of a saturated DMF solution at room tempera-
ture. m.p: 189–191 C, (1.17 g, 81%). Anal. Calc. for C12H15-
N3O2S: C, 54.26; H, 5.65; N, 15.82. Found: C, 54.53; H,
5.40; N, 16.05%; 1H NMR (DMSO-d6, d ppm): 3.28 (CH2-
Ph), 3.76 (OCH3), 5.02 (CH2‚), 5.98 (‚CH), 6.78, 7.34 (H-
aromatic), 7.87, 8.08 (NH2), 8.37 (CSANH), 9.13 (CH‚N),
11.40 (NANH); 13C NMR (DMSO-d6, d ppm): 55.8 (OACH3),
113.2 (CH2-Ph), 115.5 (CH2‚), 117.4 (‚CH), 120.1–144.3 (C-
aromatic), 147.8 (C‚N), 177.8 (C‚S).
3.2.4. N-phenyl-2-(5-allyl-3-methoxy-2-hydroxybenzylidene)
hydrazine carbothioamide (4)
A solution of 5-allyl-3-methoxy-2-hydroxybenzaldehyde
(0.57 g, 2.98 mmol) in ethanol (20 ml) was added to a solution
of 4-phenyl-3-thiosemicarbazide (0.5 g, 2.98 mmol) in ethanol
(20 ml). The resulting colorless solution was refluxed with stir-
ring for 2 h. A white fluffy product appeared in the reaction
mixture when the solution cooled down to room temperature,
which was then filtered, washed with ethanol, recrystalized and
air-dried. Yellow blocks were obtained by slow evaporation of
a saturated DMF solution at room temperature. m.p: 228–
230 C, (0.87 g, 86%). Anal. Calc. for C18H19N3O2S: C,
63.26; H, 5.56; N, 12.30. Found: C, 63.72; H, 5.97; N,
12.56%; 1H NMR (DMSO-d6, d ppm): 3.30 (CH2-Ph), 3.79
(OCH3), 5.03 (CH2‚), 5.99 (‚CH), 6.80, 7.22, 7.37, 7.45,
7.55 (H-aromatic), 8.50 (CH‚N), 9.98 (NH-Ph), 11.77
(NANH); 13C NMR (DMSO-d6, d ppm): 55.8 (OACH3),
113.3 (CH2-Ph), 115.4 (CH2‚), 117.7 (‚CH), 120.0–144.5
(C-aromatic), 147.8 (C‚N), 177.7 (C‚S).
3.3. In Vitro anticancer studies
3.3.1. Cell lines
Human colorectal carcinoma cells (HCT-116), Human breast
cancer cells (MCF-7), Human pancreatic epithlioidal carci-
noma cells (PANC-1) and normal mouse fibroblasts NIH/3T3
cells were purchased from American-type culture collection
(Rockvill, USA). HCT-116 cells were maintained in RPMIPlease cite this article in press as: Hussein, M.A. et al., Synthesis, structural elucida
Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.08.0131640 medium (Gibco, USA) whereas PANC-1, MCF-7 and
NIH/3T3 cells were maintained in DMEM medium (Gibco,
USA).
3.3.2. Anti-proliferative assay
The effect of compounds 1–4 on cell proliferation was evalu-
ated by MTT assay as described earlier (Umar et al., 2014).
The cells were harvested by trypsinization, re-suspended in
5 ml of the fresh medium and seeded thereafter in 96-well cul-
ture plates (1  105/ml). After an overnight incubation, the
cells were treated with graded doses (200, 100, 50, 25, 12.5,
6.25 lM) of compounds 1–4, 5-Fluorouracil (reference drug
for PANC-1 and HCT-116 cells) and betulinic acid (reference
drug for NIH/3T3 and MCF-7 cells). The cells were incubated
at 37 C and 5% CO2 for 48 h. Images of cells were taken by
using AMG EVOS fI inverted microscope at 20 magnifica-
tion. 20 lL of MTT reagent (5 mg/ml) was added in each well
and the cells were incubated further for 3 h at 37 C and 5%
CO2. The media were removed from each well and the crystals
of formazan were dissolved by adding 150 lL of DMSO in
each well and the absorbance was measured at 570 nm wave-
length by using microplate reader (Multi-mode microplate
reader Model Infinite 200, Tecan, Mannedorf, Switzerland).
% Inhibition was calculated using the formula:
% Inhibition ofCell Viability¼ 1ðabsorbance of sampleblankÞ½
=ðabsorbance of negative control
blankÞ100
4. Conclusions
Four new thiosemicarbazone derivatives were synthesized and
structurally elucidated. All the tested compounds remained safe
against normal cells whereas they showed significant cytotoxic-
ity in cancerous cells. Furthermore, the test compounds, specif-
ically 2 and 4, induced cytotoxicity several times better than the
standard drugs (5-Flourouracil and Betulinic acid). The results
showed that substitution of phenolic groups at terminal thioa-
mide nitrogen may enhance the biological significance of
thiosemicarbazones. Conclusively, the synthesized thiosemicar-
bazone derivatives (1–4) have worth to be further studied.
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